Table 3.
Univariate Analysis of Prognostic Factors
| Variables | OS | LRFS | DMFS | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
| Gender | 1.41 (1.18–1.70) | <0.01 | 1.36 (0.99–1.89) | 0.06 | 1.46 (1.13–1.87) | <0.01 |
| Age | 1.34 (1.15–1.56) | <0.01 | 1.39 (1.07–1.81) | <0.01 | 1.06 (0.87–1.29) | 0.55 |
| LDH | 2.47 (1.94–3.15) | <0.01 | 2.67 (1.77–4.03) | <0.01 | 2.45 (1.83–3.39) | <0.01 |
| T stage | 1.72 (1.57–1.90) | <0.01 | 2.18 (1.83–2.61) | <0.01 | 1.63 (1.45–1.85) | <0.01 |
| N stage | 1.67 (1.47–1.78) | <0.01 | 1.10 (0.83–1.30) | 0.20 | 2.08 (1.85–2.34) | <0.01 |
| TNM stage | 2.12 (1.90–2.38) | <0.01 | 2.10 (1.72–2.55) | <0.01 | 2.33 (2.01–2.72) | <0.01 |
| Chemotherapy | 1.56 (1.27–1.92) | <0.01 | 1.23 (0.84–1.82) | 0.20 | 1.60 (1.22–2.10) | <0.01 |